| Peer-Reviewed

Carotid Atherosclerosis in Asymptomatic Patients with at Least One Cardiovascular Risk Factor: A Cross-Sectional Study in Yaounde, Cameroon

Received: 8 October 2021     Accepted: 29 October 2021     Published: 10 November 2021
Views:       Downloads:
Abstract

Introduction: Atherosclerosis is a leading cause of vascular disease worldwide. One of its main locations is in the carotid artery which is implicated in 20% of ischemic strokes. This study aimed to determine the frequency of carotid atherosclerosis in a group of asymptomatic patients with at least one cardiovascular risk factor. Methodology: This was a cross-sectional study from January to June 2021 (6 months). We included consenting adults followed up at the Yaoundé Central Hospital and the Yaoundé University Teaching Hospital, aged at least 50 years and having at least one cardiovascular risk factor such as hypertension, diabetes, dyslipidemia, smoking, or obesity. A Doppler ultrasound of the supra-aortic trunks was performed on each patient. Statistical analyses were performed using the chi-2 test for bivariate analysis and binary logistic regression for multivariate analyses. The threshold of significance was set at 0.05. Results: A total of 75 participants were included of which 26 were men and 49 women. The mean age (SD) was 62.96 (8.87) years. Hypertension was seen in 93.3% of the participants, dyslipidemia in 77.3%, obesity in 48%, type 2 diabetes in 34.7%, and 9.3% were smokers. High cardiovascular risk was seen in 22 (29.4%) participants. Twenty-seven participants (36%) had one or more carotid atheroma plaques, and 11 (14.7%) participants had a stenosis plaque. Hypercholesterolemia and high cardiovascular risk were associated with the presence of carotid atheroma plaque. Conclusion: The frequency of carotid atherosclerosis appears to be high in people over 50 years of age with at least one cardiovascular risk factor justifying the importance of control strategies against these factors.

Published in Cardiology and Cardiovascular Research (Volume 5, Issue 4)
DOI 10.11648/j.ccr.20210504.12
Page(s) 166-171
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Carotid Atherosclerosis, Asymptomatic Patients, Cardiovascular Risk Factors, Yaoundé

References
[1] Maladies cardiovasculaires. [cité 18 juin 2021]. Disponible sur: https://www.who.int/fr/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
[2] Cardiovascular diseases (CVDs). [cité 6 janv 2021]. Disponible sur: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
[3] FEDECARDIO | L’athérosclérose [Internet]. https://www.fedecardio.org. 2016 [cité 7 janv 2021]. Disponible sur: https://www.fedecardio.org/Les-maladies-cardio-vasculaires/Les-pathologies-cardio-vasculaires/latherosclerose.
[4] Niu L, Zhang Y, Meng L, Xiao Y, Wong KKL, Abbott D, et al. Detection of Subclinical Atherosclerosis in Asymptomatic Subjects Using Ultrasound Radiofrequency-Tracking Technology. PLoS ONE. 4 nov 2014; 9 (11). Disponiblesur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219816/.
[5] Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak J, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the cardia and mesa studies. Circulation. 27 janv 2009; 119 (3): 382.
[6] Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modeling study - The Lancet Global Health. Disponible sur: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30117-0/fulltext.
[7] Barquera S, Pedroza-Tobías A, Medina C, Hernández-Barrera L, Bibbins-Domingo K, Lozano R, et al. Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch Med Res. juill 2015; 46 (5): 328-38.
[8] Yerly P, Rodondi N, Viswanathan B, Riesen W, Vogt P, Bovet P. Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population. Int J Cardiovasc Imaging. mars 2013; 29 (3): 589-99.
[9] Riccioni G, Sblendorio V. Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol JGC. sept 2012; 9 (3): 305-17.
[10] Baudet M, Daugareil C, Ferrieres J. Prévention des maladies cardiovasculaires et règles hygiéno-diététiques. Ann Cardiol Angéiologie. 1 avr 2012; 61 (2): 93-8.
[11] Rodríguez-Saldaña J, Rodriguez-Flores M, Cantú-Brito C, Aguirre-Garcia J. A Pathological Study of the Epidemiology of Atherosclerosis in Mexico City. Vol. 2014, Cardiology Research and Practice. p. e264205. Disponible sur: https://www.hindawi.com/journals/crp/2014/264205/.
[12] A disease transition in sub-Saharan Africa | Nature Medicine. Disponible sur: https://www.nature.com/articles/s41591-019-0659-0.
[13] The Continuing Epidemiological Transition in Sub-Saharan Africa: A Workshop Summary | The National Academies Press. [cité 28 août 2021]. Disponible sur: https://www.nap.edu/catalog/13533/the-continuing-epidemiological-transition-in-sub-saharan-africa-a-workshop.
[14] Site Specificity of Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology [Internet]. [cité 28 août 2021]. Disponible sur: https://www.ahajournals.org/doi/full/10.1161/01.atv.0000105054.43931.f0.
[15] Atherosclerosis. [cité 28 août 2021]. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826222/.
[16] Prasad K. Pathophysiology and Medical Treatment of Carotid Artery Stenosis. Int J Angiol Off Publ Int Coll Angiol Inc. sept 2015; 24 (3): 158-72.
[17] Masson E. Exploration ultrasonore en neurologie vasculaire. EM-Consulte. [cité 11 janv 2021]. Disponible sur: https://www.em-consulte.com/article/1133139/exploration-ultrasonore-en-neurologie-vasculaire.
[18] Statistics review 4: Sample size calculations | Critical Care. [cité 14 nov 2020]. Disponible sur: https://ccforum.biomedcentral.com/articles/10.1186/cc1521.
[19] Trihan J-E, Lanéelle D, Thollot C, Escure E, Belhadj-Chaidi R, Delicque J, et al. Évaluation et quantification d’une sténose carotidienne par échographie-Doppler. J Imag Diagn Interv. 1 sept 2019; 2 (4): 204-16.
[20] Kingue S, Kuaban C, Dongmol L, Nguefack C, Muna WF. [Ultrasonic demonstration of carotid atherosclerosis in black Cameroonian adults with cardiovascular risk]. Ann Cardiol Angeiol (Paris). déc 1998; 47 (10): 722-7.
[21] Soya E, Monney E, N’djessan JJ, Kouamé E, Konin C. Athérosclérose infraclinique dans une population d’hypertendus suivis à l’institut de cardiologie d’Abidjan. JMV-J Médecine Vasc. mars 2017; 42 (2): 108.
[22] Head T, Daunert S, Goldschmidt-Clermont PJ. The Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeostasis. Front Genet. 14 déc 2017; 8: 216.
[23] Aging and Atherosclerosis | Circulation Research. [cité 29 août 2021]. Disponible sur: https://www.ahajournals.org/doi/full/10.1161/circresaha.111.261388.
[24] Chapter 75. Aging and Atherosclerosis | Hazzard’s Geriatric Medicine and Gerontology, 6e | AccessMedicine | McGraw Hill Medical. [cité 29 août 2021]. Disponible sur: https://accessmedicine.mhmedical.com/content.aspx?bookid=371&sectionid=41587690.
[25] BeLue R, Okoror TA, Iwelunmor J, Taylor KD, Degboe AN, Agyemang C, et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Glob Health. 22 sept 2009; 5 (1): 10.
[26] Moran A, Forouzanfar M, Sampson U, Chugh S, Feigin V, Mensah G. The Epidemiology of Cardiovascular Diseases in Sub-Saharan Africa: The Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Prog Cardiovasc Dis. 2013; 56 (3): 234-9.
[27] Cardiovascular risk factors in sub-Saharan Africa: a review - AMEC - Associazione per la Terapia delle Malattie Metaboliche e Cardiovascolari. [cité 29 août 2021]. Disponible sur: https://www.associazioneamec.com/letteratura/cardiovascular-risk-factors-in-sub-saharan-africa-a-review.
[28] Nonga B, JC Mb. Prevalence of Significant Carotid Stenosis and Other Risk Factors in Patients with Acute Ischemic Stroke in Yaounde, Cameroon. J Vasc Med Surg. 1 janv 2016; 04.
[29] Nelson RH. Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Prim Care. mars 2013; 40 (1): 195-211.
[30] Role of Cholesterol as a Risk Factor in Cardiovascular Diseases | IntechOpen. [cité 29 août 2021]. Disponible sur: https://www.intechopen.com/chapters/61333.
[31] Risk Factors for Atherosclerosis. [cité 29 août 2021]. Disponible sur: https://www.news-medical.net/health/Risk-Factors-for-Atherosclerosis.aspx.
[32] Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SWJ, van der Schouw YT. Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men. Circulation. 4 mai 2004; 109 (17): 2074-9.
[33] Xing D, Nozell S, Chen Y-F, Hage F, Oparil S. Estrogen and Mechanisms of Vascular Protection. Arterioscler Thromb Vasc Biol. 1 mars 2009; 29 (3): 289-95.
[34] Reslan OM, Khalil RA. Vascular Effects of Estrogenic Menopausal Hormone Therapy. Rev Recent Clin Trials. 1 févr 2012; 7 (1): 47-70.
[35] Meng Q, Li Y, Ji T, Chao Y, Li J, Fu Y, et al. Estrogen prevent atherosclerosis by attenuating endothelial cell pyroptosis via activation of estrogen receptor α-mediated autophagy. J Adv Res. 1 févr 2021; 28: 149-64.
[36] Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress. [cité 29 août 2021]. Disponible sur: https://www.hindawi.com/journals/omcl/2021/5523516/.
[37] Mathur RK. Role of diabetes, hypertension, and cigarette smoking on atherosclerosis. J Cardiovasc Dis Res. 2010; 1 (2): 64-8.
[38] Cigarette Smoking and Progression of Atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study | Cardiology | JAMA | JAMA Network. [cité 29 août 2021]. Disponible sur: https://jamanetwork.com/journals/jama/fullarticle/1150354.
Cite This Article
  • APA Style

    Liliane Mfeukeu-Kuate, Honoré Yemele Kemnang, Christine Fahrida Ngalla, Ahmadou Musa Jingi, Eric Savom, et al. (2021). Carotid Atherosclerosis in Asymptomatic Patients with at Least One Cardiovascular Risk Factor: A Cross-Sectional Study in Yaounde, Cameroon. Cardiology and Cardiovascular Research, 5(4), 166-171. https://doi.org/10.11648/j.ccr.20210504.12

    Copy | Download

    ACS Style

    Liliane Mfeukeu-Kuate; Honoré Yemele Kemnang; Christine Fahrida Ngalla; Ahmadou Musa Jingi; Eric Savom, et al. Carotid Atherosclerosis in Asymptomatic Patients with at Least One Cardiovascular Risk Factor: A Cross-Sectional Study in Yaounde, Cameroon. Cardiol. Cardiovasc. Res. 2021, 5(4), 166-171. doi: 10.11648/j.ccr.20210504.12

    Copy | Download

    AMA Style

    Liliane Mfeukeu-Kuate, Honoré Yemele Kemnang, Christine Fahrida Ngalla, Ahmadou Musa Jingi, Eric Savom, et al. Carotid Atherosclerosis in Asymptomatic Patients with at Least One Cardiovascular Risk Factor: A Cross-Sectional Study in Yaounde, Cameroon. Cardiol Cardiovasc Res. 2021;5(4):166-171. doi: 10.11648/j.ccr.20210504.12

    Copy | Download

  • @article{10.11648/j.ccr.20210504.12,
      author = {Liliane Mfeukeu-Kuate and Honoré Yemele Kemnang and Christine Fahrida Ngalla and Ahmadou Musa Jingi and Eric Savom and Jean Claude Mballa Amougou and Ba Hamadou and Bernadette Ngo Nonga and Alain Patrick Menanga},
      title = {Carotid Atherosclerosis in Asymptomatic Patients with at Least One Cardiovascular Risk Factor: A Cross-Sectional Study in Yaounde, Cameroon},
      journal = {Cardiology and Cardiovascular Research},
      volume = {5},
      number = {4},
      pages = {166-171},
      doi = {10.11648/j.ccr.20210504.12},
      url = {https://doi.org/10.11648/j.ccr.20210504.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210504.12},
      abstract = {Introduction: Atherosclerosis is a leading cause of vascular disease worldwide. One of its main locations is in the carotid artery which is implicated in 20% of ischemic strokes. This study aimed to determine the frequency of carotid atherosclerosis in a group of asymptomatic patients with at least one cardiovascular risk factor. Methodology: This was a cross-sectional study from January to June 2021 (6 months). We included consenting adults followed up at the Yaoundé Central Hospital and the Yaoundé University Teaching Hospital, aged at least 50 years and having at least one cardiovascular risk factor such as hypertension, diabetes, dyslipidemia, smoking, or obesity. A Doppler ultrasound of the supra-aortic trunks was performed on each patient. Statistical analyses were performed using the chi-2 test for bivariate analysis and binary logistic regression for multivariate analyses. The threshold of significance was set at 0.05. Results: A total of 75 participants were included of which 26 were men and 49 women. The mean age (SD) was 62.96 (8.87) years. Hypertension was seen in 93.3% of the participants, dyslipidemia in 77.3%, obesity in 48%, type 2 diabetes in 34.7%, and 9.3% were smokers. High cardiovascular risk was seen in 22 (29.4%) participants. Twenty-seven participants (36%) had one or more carotid atheroma plaques, and 11 (14.7%) participants had a stenosis plaque. Hypercholesterolemia and high cardiovascular risk were associated with the presence of carotid atheroma plaque. Conclusion: The frequency of carotid atherosclerosis appears to be high in people over 50 years of age with at least one cardiovascular risk factor justifying the importance of control strategies against these factors.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Carotid Atherosclerosis in Asymptomatic Patients with at Least One Cardiovascular Risk Factor: A Cross-Sectional Study in Yaounde, Cameroon
    AU  - Liliane Mfeukeu-Kuate
    AU  - Honoré Yemele Kemnang
    AU  - Christine Fahrida Ngalla
    AU  - Ahmadou Musa Jingi
    AU  - Eric Savom
    AU  - Jean Claude Mballa Amougou
    AU  - Ba Hamadou
    AU  - Bernadette Ngo Nonga
    AU  - Alain Patrick Menanga
    Y1  - 2021/11/10
    PY  - 2021
    N1  - https://doi.org/10.11648/j.ccr.20210504.12
    DO  - 10.11648/j.ccr.20210504.12
    T2  - Cardiology and Cardiovascular Research
    JF  - Cardiology and Cardiovascular Research
    JO  - Cardiology and Cardiovascular Research
    SP  - 166
    EP  - 171
    PB  - Science Publishing Group
    SN  - 2578-8914
    UR  - https://doi.org/10.11648/j.ccr.20210504.12
    AB  - Introduction: Atherosclerosis is a leading cause of vascular disease worldwide. One of its main locations is in the carotid artery which is implicated in 20% of ischemic strokes. This study aimed to determine the frequency of carotid atherosclerosis in a group of asymptomatic patients with at least one cardiovascular risk factor. Methodology: This was a cross-sectional study from January to June 2021 (6 months). We included consenting adults followed up at the Yaoundé Central Hospital and the Yaoundé University Teaching Hospital, aged at least 50 years and having at least one cardiovascular risk factor such as hypertension, diabetes, dyslipidemia, smoking, or obesity. A Doppler ultrasound of the supra-aortic trunks was performed on each patient. Statistical analyses were performed using the chi-2 test for bivariate analysis and binary logistic regression for multivariate analyses. The threshold of significance was set at 0.05. Results: A total of 75 participants were included of which 26 were men and 49 women. The mean age (SD) was 62.96 (8.87) years. Hypertension was seen in 93.3% of the participants, dyslipidemia in 77.3%, obesity in 48%, type 2 diabetes in 34.7%, and 9.3% were smokers. High cardiovascular risk was seen in 22 (29.4%) participants. Twenty-seven participants (36%) had one or more carotid atheroma plaques, and 11 (14.7%) participants had a stenosis plaque. Hypercholesterolemia and high cardiovascular risk were associated with the presence of carotid atheroma plaque. Conclusion: The frequency of carotid atherosclerosis appears to be high in people over 50 years of age with at least one cardiovascular risk factor justifying the importance of control strategies against these factors.
    VL  - 5
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

  • Faculty of Health Sciences, Department of Clinical Sciences, University of Bamenda, Bamenda, Cameroon

  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

  • Faculty of Medicine and Pharmaceutical Sciences, Department of Clinical Sciences, University of Douala, Douala, Cameroon

  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

  • Sections